Medtronic said Monday that it had entered into an agreement to acquire Heartware in a $1.1 billion deal which will help it expand its current portfolio of heart products. According to the terms of the deal, Medtronic will pay $58 per share of Heartware, which translates to a 93% premium over Heartware’s closing price on Friday. Below we discuss the key reasons as to why Medtronic might be considering this acqusition:
Please to comment